Table 1 Expression of TAZ and β-catenin proteins in different disease of EGJ
From: Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
Total | TAZ | Nuclear β-catenin | Membranous β-catenin | ||||
|---|---|---|---|---|---|---|---|
(n) | Positive (%) | Negative (%) | Positive (%) | Negative (%) | Abnormal (%) | Normal (%) | |
Normal mucosa | 37 | 6(16.2) | 31(83.8) | 7(18.9) | 30(81.1) | 10(27) | 27(73) |
Dysplasia | 41 | 29*** (70.7) | 12 (29.3) | 17* (41.5) | 31(58.5) | 12(29.3) | 29(70.7) |
AEG | 135 | 55**#(40.7) | 80 (59.3) | 69*** (51.1) | 66(48.9) | 77**#(57) | 58(43) |